top of page

OUR PROGRAMME AND SELECTION OF SPEAKERS (DRAFT)

We are very proud that we could convince globally recognized Speakers to join our Investors Congress. We are sure that all Participants will benefit from the Exchange of Excellence!

 

All Key Notes, Presentations and Panel Discussions will be recorded and a Transcription will be officially published as a Congress Summary and Scientific Publication!

Download our Congress Broschure

Get all Information about our next Investors Congress "Exchange of Excellence", 13. - 15. September 2024.

BTS-Investors-Congress_0924.png
AGENDA - OVERVIEW

OUR EVENT AGENDA - Overview

Programm0924_day1.jpg
Programm0924_day2_2.jpg
INVITED INVSTORS & PARTICIPANTS

"Exchange of Excellence"-Congress

FIND OUT MORE ABOUT SOME SPECIAL PROJECTS ON OUR CONGRESS

With these Interviews, you might wonder that we talk about the Congress in March. This is not done by mistake. All below listed Participants took already part in our Congress in March, but they were so satisfied with the Results of the Event that they all applied to take part in the October-Congress either. For some as Participants to meet the Partners they have already acquired, some as Speakers to continue the common Process and to contribute to the "Exchange of Excellence". We have decided to take these Interviews and leave them online, so that also new potential Partners can collect as many Information about these great Projects as possible.

You find some of the former Key Notes also on our "Impressions"-Website!

PELICATT stands for Pathogen ELImination through Complement Activation Targeting Technology. Professor Dr. Hans-Wilhelm Schwäble´s research collaboration (University of Cambridge) has generated a new line of modified antibodies targeting the cell surface of malignant cells and the cell surface of bacterial pathogens. These modified antibodies induced enhanced activation of the host’s complement system on the surface of target cells. The Company is now looking for Investment Partners and for strategic Partners to set up a new facility in the UAE.

OXI ZEN is a technology platform for assessing, quantifying and trading REAL science-verified carbon sequestration capacity, secured and tracked through blockchain technology. With OXI ZEN the UAE can achieve its gal to become CO2 neutral not in 2050, but in 2025 – science verified! Over 100 million metric tons of verified carbon sequestration capacity available for sale!

Prof. Dr. Andreas Furrer LL.M. explains how ZENOTTA has developed the new blockchain (NOAM) with the sole purpose to generate & manage Smart Data. Zenotta can digitally create, maintain and transact the value of each and any kind of data.
More information under www.zenotta.xyz

SYNOCURA is a very advanced supplier of medical goods in Europe! They are very successful with the supply of COVID Antigen-Test and especially Tests for children at school (so called lollipop tests). SYNOCURA wants to enter the UAE and Arab Markets - Quality at a favorable price. 

Dr. Nicolas Krämer explains the INVITACARE Concept: The Establishment and Operation of a comprehensive concept of Psychosomatic Clinics - in Europe and the United Arab Emirates.

INVESTORS CONGRESS "Exchange of Excellence"

OUR INVITED PARTICIPANTS AND INVESTMENT COMPANIES

Overview of Participants of the Bridge to Success Investors Congress

Use the Opportunity of
a free and non-binding Conference Call!

Zwei Männer Hände schütteln

Whether you are looking for Corporate or Project Financing Solution, or if you want to expand the markets for your products to Asia, the USA or the Arab world, or even if you want to establish foreign companies and see the advantages of a residence in Dubai. Feel invited to a non-binding Consultation. We are looking forward to the common Online Meeting!

INTERVIEWS
bottom of page